Cognitive Neurosciences has experienced much forward momentum since In Vivo last spoke to the Vancouver, Canada company about its innovative, culture- and language-agnostic cognitive assessment tool.
Driving improvements in early-stage diagnosis is the chief aim of technologies being developed for use in the dementia market, but two years ago, Cognetivity Neurosciences was finding it hard to...
Co-founder and CEO of the company Sina Habibi, one of In Vivo’s 2021 Rising Leaders, then took the innovative step of advertising the test protocol to interested UK NHS trusts....